Special Considerations in the Management of HIV-Infected Patients From Minority Communities
Summary
- Study ACTG 5202 compared atazanavir/ritonavir or efavirenz with either emtricitabine/tenofovir DF or abacavir/lamivudine in treatment-naive patients[Smith 2014]
- Of enrollees, 33% of participants were non-Hispanic blacks and 23% were Hispanic
- Black race was associated with greater likelihood of virologic failure across all treatment regimens
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content